MAIA Biotechnology Inc (AMEX:MAIA) has a beta value of 0.23 and has seen 2.21 million shares traded in the last trading session. The company, currently valued at $60.29M, closed the last trade at $2.38 per share which meant it gained $0.32 on the day or 15.53% during that session. The MAIA stock price is -151.68% off its 52-week high price of $5.99 and 58.4% above the 52-week low of $0.99. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.14 million shares traded. The 3-month trading volume is 176.38K shares.
MAIA Biotechnology Inc (AMEX:MAIA) trade information
Sporting 15.53% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MAIA stock price touched $2.38 or saw a rise of 6.67%. Year-to-date, MAIA Biotechnology Inc shares have moved 20.20%, while the 5-day performance has seen it change 18.41%. Over the past 30 days, the shares of MAIA Biotechnology Inc (AMEX:MAIA) have changed 20.20%. Short interest in the company has seen 0.66 million shares shorted with days to cover at 10.99.
MAIA Biotechnology Inc (MAIA) estimates and forecasts
Figures show that MAIA Biotechnology Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -36.87% over the past 6 months, with this year growth rate of 12.75%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -25.01% over the past 5 years.
MAIA Dividends
MAIA Biotechnology Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
MAIA Biotechnology Inc (AMEX:MAIA)’s Major holders
Insiders own 17.49% of the company shares, while shares held by institutions stand at 7.51% with a share float percentage of 9.10%. Investors are also buoyed by the number of investors in a company, with MAIA Biotechnology Inc having a total of 20.0 institutions that hold shares in the company. The top two institutional holders are HALTER FERGUSON FINANCIAL INC. with over 0.72 million shares worth more than $2.47 million. As of 2024-06-30, HALTER FERGUSON FINANCIAL INC. held 4.1% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 0.54 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.84 million and represent 3.051% of shares outstanding.
